Abstract:Objective The objective of the study was to compare the effective rate, cure rate, adverse reaction rate, and effective time of three methods in the treatment of infantile hemangioma, hoping to provide reference for improving the clinical therapeutic effect. Methods This is a retrospective study of 307 infantile hemangioma patients admitted to the Department of Oral and Maxillofacial Surgery, School of Stomatology, China Medical University, from January 2014 to October 2021. The patients were divided into three groups. In group A, timolol maleate solution was introduced by the nano-microneedle technique (97 cases); in group B, timolol maleate drops dipped in medical swabs were applied (107 cases); and group C patients took propranolol orally (103 cases). The effective rate, cure rate, adverse reaction rate, and effective time of treatment were recorded and compared. Results The total effective rate, total cure rate, and total adverse reaction rate of the three groups were 87.6, 65.2, and 9.4%, respectively. The results showed that the effective and cure rates of group A were higher than those of group B (92.8 and 76.3%, respectively; p < 0.05), the adverse reaction rate of group C was higher than that of group B (17.5%, p < 0.05), and the effective time of group A was shorter than that of groups B and C. In most patients, symptoms significantly improved within 2 months ( p < 0.05). Conclusion Timolol maleate introduced by nanometer microneedles is an effective and safe treatment for superficial hemangioma in infants with the highest effective and cure rates, lower incidence of adverse reactions, and the shortest effective treatment time. Received: 27 December 2022 Accepted: 14 March 2023 Article published online: 01 May 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Evaluation of Transdermal Transport and Concurrent Cutaneous Hydrolysis of Timolol Prodrug for the Treatment of Infantile Hemangiomas

A prospective self-controlled study of topical timolol 0.5% cream for large superficial infantile hemangiomas.

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma.

Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas

Effect of Timolol Maleate Gel-forming Solution in the Treatment of Superficial Infantile Hemangiomas: a Prospective, Randomized, Double-Blind, Controlled Trial

Fractional Carbon Dioxide Laser-Assisted Drug Delivery of Topical Timolol Solution for the Treatment of Deep Infantile Hemangioma: a Pilot Study.

Efficacy and Safety of Oral Propranolol or Topical Timolol for the Treatment of Superficial Infantile Hemangiomas

Formulation, Characterization and Clinical Evaluation of Propranolol Hydrochloride Gel for Transdermal Treatment of Superficial Infantile Hemangioma.

Prospective, Open-Label, Rater-Blinded and Self-Controlled Pilot Study of the Treatment of Proliferating Superficial Infantile Hemangiomas with 0.5% Topical Timolol Cream Versus 595-Nm Pulsed Dye Laser

Comparison of Simply Topical Timolol 0.5% Cream and Combined with Intralesional Diprospan Injection for the Treatment of Thick Superficial Infantile Hemangiomas

Chinese Expert Consensus on the Use of Topical Timolol Maleate Treatment of Infantile Hemangiomas

Predictors of Treatment Responses of Superficial Infantile Hemangiomas to Topical Timolol.

[Topical Timolol in the Treatment of Periocular Superficial Infantile Hemangiomas: a Prospective Study].

Open-Label Nonrandomized Left-Right Comparison of Imiquimod 5% Ointment and Timolol Maleate 0.5% Eye Drops in the Treatment of Proliferating Superficial Infantile Hemangioma

Efficacy and Safety of Introduction Timolol Maleate by Manometer Microneedles among Infantile Hemangioma: A Retrospective Study in China

Imiquimod 5% Cream Versus Timolol 0.5% Ophthalmic Solution for Treating Superficial Proliferating Infantile Haemangiomas: a Retrospective Study

Comparison of the efficacy and safety of lasers, topical timolol, and combination therapy for the treatment of infantile hemangioma: a meta‐analysis of 10 studies

Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study

A Self‐controlled Study of Intralesional Injection of Diprospan Combined with Topical Timolol Cream for Treatment of Thick Superficial Infantile Hemangiomas

The Effect of 0.5% Topical Timolol Cream on Regression of Superficial Infantile Haemangioma in the Involuting Phase: a Prospective, Randomized, Self-Controlled Study

Comparison of Oral Propranolol Alone and Combined with Topical 0.5 ％ Timolol Maleate Cream for the Treatment of Infantile Hemangiomas